Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01650844 · ClinicalTrials.gov registry record · NA

School-Based Telemedicine Enhanced Asthma Management

A NA study, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
400
Enrollment target

NCT01650844: Completed NA study, sponsored by University of Rochester.

NCT01650844 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01650844, a NA study, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
400 participants
Enrollment target

Study Summary

This project aims to improve guideline-based asthma care using enhanced communication and screening tools, telemedicine and directly observed therapy of preventive medications in city schools. Web-based screening will be used to identify children with persistent or poorly controlled asthma and to send reports to the child's primary care doctor. Children in the SB-TEAM group will receive a telemedicine asthma assessment in school and be prescribed a daily preventive asthma medication to be taken through school-based directly observed therapy. The overall aim of this study is to evaluate the use of the SB-TEAM intervention for improving guideline based care, enhancing adherence to effective preventive medications and at reducing morbidity among young urban children with asthma.

Primary Outcome

The primary outcome measure is asthma morbidity between groups. We will measure asthma morbidity by looking at the average number of days without asthma symptoms (symptom free days) over 2 weeks, during each follow-up assessment during the peak winter season (November-March). Symptom free days are defined as 24 hour periods of no asthma symptoms including, coughing, wheezing, tightness in the chest or shortness of breath. The number of symptom free days will be reported by the child's caregiver.

Interventions

  • OTHER Enhanced Usual Care
  • OTHER School-Based Telemedicine Enhanced Asthma Management

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2012-08
Est. Completion 2018-07
Phase NA
University of Rochester

636 total trials

What the finished NCT01650844 record still lists

NCT01650844 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).

The record links to 0 conditions, and to 2 interventions - of which Enhanced Usual Care is the first listed.

NCT01650844 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01650844 about?

NCT01650844 is a clinical study titled "School-Based Telemedicine Enhanced Asthma Management". This project aims to improve guideline-based asthma care using enhanced communication and screening tools, telemedicine and directly observed therapy of preventive medications in city schools. Web-based screening will be used to identify children with persistent or poorly controlled asthma and to se...

What is the current status of trial NCT01650844?

This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2012-08. Estimated completion is 2018-07.

What interventions are being tested in trial NCT01650844?

The interventions under investigation include: Enhanced Usual Care (OTHER), School-Based Telemedicine Enhanced Asthma Management (OTHER).

Who is sponsoring clinical trial NCT01650844?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01650844's enrollment target sits among peer trials

400 246th of 2000 higher than 1,734 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01650844, the US trial registry maintained by the National Library of Medicine. NCT01650844 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.